Basel, Switzerland

Ku-Hua Ji

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ku-Hua Ji. Retrieved from https://idiyas.com/inventor/ku-hua-ji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ku-Hua Ji in Antimycotic and Cholesterol-Lowering Agents

Introduction

Ku-Hua Ji is an accomplished inventor based in Basel, Switzerland, known for his contributions to the field of medicinal chemistry. His significant work has led to the development of innovative compounds with practical applications in health care, particularly in tackling antifungal infections and managing cholesterol levels.

Latest Patents

Ku-Hua Ji holds a patent for tertiary amines of the formula specified in his patent document. The compounds he developed show promising antimycotic and cholesterol-lowering activity, which could be pivotal in pharmaceutical advancements. This patent adds to the body of knowledge in medicinal chemistry, offering potential treatments for medical conditions associated with fungal infections and high cholesterol.

Career Highlights

Throughout his career, Ku-Hua Ji has been affiliated with Hoffmann-La Roche Inc., a leading research-focused healthcare company. His work in this esteemed organization showcases his dedication to innovation and his role in pushing the boundaries of therapeutics.

Collaborations

In his professional journey, Ku-Hua Ji has collaborated with talented colleagues such as Johannes Aebi and Henrietta Dehmlow. These collaborations highlight the importance of teamwork in scientific research and the development of new technologies.

Conclusion

Ku-Hua Ji's contributions in the field of antimycotic agents and cholesterol-lowering compounds underscore the significance of innovation in medical research. His patented inventions represent a step forward in addressing pressing health issues and pave the way for further advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…